Svas Biosana S.p.A. (BIT:SVS)

Market Cap	43.57M
Revenue (ttm)	122.29M
Net Income (ttm)	5.87M
Shares Out	5.31M
EPS (ttm)	1.10
PE Ratio	7.44
Forward PE	5.86
Dividend	0.25 (3.07%)
Ex-Dividend Date	Jun 9, 2025

Volume	1,830
Average Volume	1,855
Open	8.26
Previous Close	8.18
Day's Range	8.16 - 8.26
52-Week Range	6.48 - 8.80
Beta	0.93
RSI	52.96
Earnings Date	Sep 26, 2025

About Ligand Pharmaceuticals

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in onc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 327
• Stock Exchange: Borsa Italiana
• Ticker Symbol: SVS

Financial Performance

In 2024, Svas Biosana's revenue was 122.29 million, an increase of 0.54% compared to the previous year's 121.63 million. Earnings were 5.87 million, an increase of 14.68%.